Dilon Diagnostics

12050 Jefferson Ave.
12050 Jefferson Ave. Newport News, VA, USA 23606
eMail:
Website:
https://www.dilon.com
Phone:757-269-4910
Dilon Diagnostics is a brand of Dilon Technologies. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI/MBI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake.
Latest from Dilon Diagnostics
Molecular Imaging
SmartBreast joins forces with FITI
By AuntMinnie.com staff writers
On the heels of its acquisitions of molecular breast imaging (MBI) assets from GE Healthcare and Dilon Diagnostics, SmartBreast has signed on FoxSemicon Integrated Technologies (FITI) to manufacture its new MBI systems.
February 8, 2021
2021 02 09 19 30 0389 2021 02 09 Smart Breast E680 400
Molecular Imaging
SmartBreast buys molecular breast imaging business from GE
By Brian Casey
Breast cancer screening firm SmartBreast has acquired assets related to the Discovery NM750b molecular breast imaging (MBI) business of GE Healthcare, including scanner designs, patents, and service contracts for GE's MBI installed base.
February 7, 2021
2021 02 08 05 20 0858 2021 02 08 Smartbreast Mbi System Square
Molecular Imaging
AuntMinnie.com Molecular Imaging Insider
By Brian Casey
January 12, 2021
Breast
SmartBreast acquires molecular breast tech from Dilon
By AuntMinnie.com staff writers
Private breast cancer screening firm SmartBreast has acquired molecular breast imaging technologies and patents from developer Dilon Diagnostics.
January 3, 2021
2021 01 04 20 06 5281 2021 01 04 Dilon Smartbreast 20210104205854
Nuclear Medicine
Dilon buys Dune Medical's assets
By AuntMinnie.com staff writers
Molecular breast imaging developer Dilon Diagnostics has acquired the assets of Dune Medical, including the company's MarginProbe device for identifying positive margins during breast conservation surgery.
April 2, 2020
2018 08 10 21 39 0206 Breast Cancer2 400
Nuclear Medicine
Dilon points to new ACR practice parameter
By AuntMinnie.com staff writers
Molecular breast imaging technology developer Dilon Diagnostics said the American College of Radiology (ACR) has adopted its first practice parameter for molecular breast imaging.
October 10, 2017
Molecular Imaging
FDA clears GE MBI biopsy accessory
By AuntMinnie.com staff writers
GE Healthcare and molecular breast imaging developer Dilon Diagnostics announced the U.S. Food and Drug Administration (FDA) clearance of GE's molecular breast imaging (MBI) localization accessory for breast biopsy.
November 26, 2016
Nuclear Medicine
Dilon, GE ink distribution deal
By AuntMinnie.com staff writers
Molecular breast imaging developer Dilon Diagnostics has signed on to be the exclusive distributor of GE Healthcare's Discovery NM750b molecular breast imaging system in North America.
November 15, 2016
Nuclear Medicine
Dilon updates Navigator gamma probe
By AuntMinnie.com staff writers
Molecular breast imaging developer Dilon Diagnostics has released a new version of its gamma probe system for sentinel lymph node biopsy.
July 6, 2016
Nuclear Medicine
Dilon highlights molecular breast tomo device at SNMMI
By AuntMinnie.com staff writers
Molecular breast imaging developer Dilon Diagnostics is highlighting new molecular breast tomosynthesis technology at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in San Diego.
June 13, 2016
Nuclear Medicine
Dilon, GE present breast biopsy tool at SBI
By AuntMinnie.com staff writers
Dilon Diagnostics and GE Healthcare will present a breast biopsy localization tool for GE's Discovery NM750b molecular breast imaging system at the Society of Breast Imaging (SBI) meeting in Austin, TX.
April 6, 2016
Nuclear Medicine
Dilon signs distribution deal with GE
By AuntMinnie.com staff writers
Dilon Diagnostics has inked a deal to distribute GE Healthcare's Discovery NM750b molecular breast imaging system to select areas around the world.
November 23, 2015
Nuclear Medicine
Dilon touts MBI for invasive lobular carcinoma
By AuntMinnie.com staff writers
Molecular breast imaging (MBI) developer Dilon Diagnostics is highlighting a study that suggests MBI is a sensitive technique for diagnosing invasive lobular carcinoma, a breast cancer that tends to be difficult to detect.
July 16, 2015
Nuclear Medicine
Dilon: Patient wins legal appeal for MBI coverage
By AuntMinnie.com staff writers
Dilon Diagnostics said a patient has won a legal battle to obtain health insurance coverage of her molecular breast imaging (MBI) study.
June 1, 2014
Nuclear Medicine
Digirad expands relationship with Dilon
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad has inked an exclusive international distribution agreement with molecular breast imaging developer Dilon Diagnostics.
August 21, 2013